Menu
GWAS Study

Meta-analysis identifies novel risk loci and yields systematic insights into the biology of male-pattern baldness.

Heilmann-Heimbach S, Herold C, Hochfeld LM et al.

28272467 PubMed ID
GWAS Study Type
22518 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

HS
Heilmann-Heimbach S
HC
Herold C
HL
Hochfeld LM
HA
Hillmer AM
ND
Nyholt DR
HJ
Hecker J
JA
Javed A
CE
Chew EG
PS
Pechlivanis S
DD
Drichel D
HX
Heng XT
DR
Del Rosario RC
FH
Fier HL
PR
Paus R
RR
Rueedi R
GT
Galesloot TE
MS
Moebus S
AT
Anhalt T
PS
Prabhakar S
LR
Li R
KS
Kanoni S
PG
Papanikolaou G
KZ
Kutalik Z
DP
Deloukas P
PM
Philpott MP
WG
Waeber G
ST
Spector TD
VP
Vollenweider P
KL
Kiemeney LA
DG
Dedoussis G
RJ
Richards JB
NM
Nothnagel M
MN
Martin NG
BT
Becker T
HD
Hinds DA
NM
Nöthen MM
Chapter II

Abstract

Summary of the research findings

Male-pattern baldness (MPB) is a common and highly heritable trait characterized by androgen-dependent, progressive hair loss from the scalp. Here, we carry out the largest GWAS meta-analysis of MPB to date, comprising 10,846 early-onset cases and 11,672 controls from eight independent cohorts. We identify 63 MPB-associated loci (P<5 × 10-8, METAL) of which 23 have not been reported previously. The 63 loci explain ∼39% of the phenotypic variance in MPB and highlight several plausible candidate genes (FGF5, IRF4, DKK2) and pathways (melatonin signalling, adipogenesis) that are likely to be implicated in the key-pathophysiological features of MPB and may represent promising targets for the development of novel therapeutic options. The data provide molecular evidence that rather than being an isolated trait, MPB shares a substantial biological basis with numerous other human phenotypes and may deserve evaluation as an early prognostic marker, for example, for prostate cancer, sudden cardiac arrest and neurodegenerative disorders.

10,846 European ancestry cases, 11,672 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

22518
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Australia, Germany, Netherlands, Switzerland, U.K., Greece
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.